

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.80901080 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.80901080 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.80901080 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.80901080 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.80901080 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.80901080 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.53487360 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.53487360 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.44089958 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 6.04556355 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.97608647 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.53808453 |
| 13 | detection of other organism (GO:0098543) | 5.34841712 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.33980942 |
| 15 | detection of external biotic stimulus (GO:0098581) | 5.18723257 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 5.15907533 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.15898756 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14893298 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.04593434 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00618278 |
| 21 | microglial cell activation (GO:0001774) | 4.89360238 |
| 22 | response to peptidoglycan (GO:0032494) | 4.82753400 |
| 23 | detection of bacterium (GO:0016045) | 4.77299419 |
| 24 | cellular extravasation (GO:0045123) | 4.74005802 |
| 25 | response to host immune response (GO:0052572) | 4.66374250 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.66374250 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55598209 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.53939473 |
| 29 | detection of biotic stimulus (GO:0009595) | 4.53202761 |
| 30 | leukocyte aggregation (GO:0070486) | 4.52923069 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 4.51379888 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.48644728 |
| 33 | macrophage activation (GO:0042116) | 4.39095793 |
| 34 | response to interleukin-15 (GO:0070672) | 4.35316508 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.34895842 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.33578193 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32214211 |
| 38 | neutrophil activation (GO:0042119) | 4.30569579 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.27731752 |
| 40 | response to host (GO:0075136) | 4.27731752 |
| 41 | response to host defenses (GO:0052200) | 4.27731752 |
| 42 | respiratory burst (GO:0045730) | 4.25637896 |
| 43 | neutrophil mediated immunity (GO:0002446) | 4.16165041 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 4.01584107 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.00043236 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88211428 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.86813279 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.86537245 |
| 49 | granulocyte activation (GO:0036230) | 3.86267599 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.79864324 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.78523681 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73353482 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.68148099 |
| 54 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.62414587 |
| 55 | myeloid leukocyte mediated immunity (GO:0002444) | 3.61019483 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.60811594 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56644399 |
| 58 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.56088526 |
| 59 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.46158867 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.44848363 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.39162312 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.39162312 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 3.38110443 |
| 64 | response to type I interferon (GO:0034340) | 3.36284224 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.31440364 |
| 66 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.29150629 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.29150629 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 3.27466809 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24437977 |
| 70 | dendritic cell migration (GO:0036336) | 3.23610931 |
| 71 | defense response to protozoan (GO:0042832) | 3.22540303 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18593389 |
| 73 | germinal center formation (GO:0002467) | 3.15714706 |
| 74 | regulation of B cell differentiation (GO:0045577) | 3.14967121 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 3.14786903 |
| 76 | leukocyte degranulation (GO:0043299) | 3.14226272 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.13185370 |
| 78 | dendritic cell chemotaxis (GO:0002407) | 3.12128650 |
| 79 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11248099 |
| 80 | regulation of tolerance induction (GO:0002643) | 3.09930364 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06936700 |
| 82 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06856207 |
| 83 | B cell mediated immunity (GO:0019724) | 3.05442224 |
| 84 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.05233431 |
| 85 | negative regulation of B cell mediated immunity (GO:0002713) | 3.05233431 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 3.03223544 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02333787 |
| 88 | negative thymic T cell selection (GO:0045060) | 3.02109711 |
| 89 | myeloid leukocyte activation (GO:0002274) | 3.01220092 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99812797 |
| 91 | negative T cell selection (GO:0043383) | 2.99524446 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99448544 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 2.98688783 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.98016810 |
| 95 | neutrophil chemotaxis (GO:0030593) | 2.96400358 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95889489 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93963471 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 2.93187998 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.91633622 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.89480538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.69202146 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.66265008 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.64917350 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.35985963 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.17066339 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91560612 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45148326 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44300655 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10565466 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.09615579 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03528797 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.98620726 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95413028 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94973906 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.89473825 |
| 16 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.60829942 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.48932014 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.45731424 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.43496073 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.39379542 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35898801 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32178024 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.23182460 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22606897 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19652998 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19403228 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19243273 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19020360 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15684303 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08788866 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.06565465 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96429705 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96071277 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93611860 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.91516162 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88925362 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86395281 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82098495 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73875996 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71941711 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69328230 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67579722 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.62740619 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58609163 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56646200 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56017408 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55157000 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.54741393 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51862899 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49999557 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49526926 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47433864 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43509515 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43247787 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39614118 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38440601 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37732655 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35399862 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34653677 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29122674 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28594093 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28147813 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26470490 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26437095 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23057103 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22877148 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22363465 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21835967 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20797142 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19384860 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19111084 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15666634 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14402300 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13610485 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13388456 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12210203 |
| 77 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09497407 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05694264 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05474483 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04813136 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04256203 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03406811 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01419048 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97413120 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96716960 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95760636 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94957023 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91972201 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91939315 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88804125 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85605848 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83101306 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82699395 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80944270 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75296987 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70950997 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70852721 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65302192 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.64830839 |
| 100 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64604168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 6.00316953 |
| 2 | MP0003436_decreased_susceptibility_to | 4.12666406 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.81011549 |
| 4 | MP0003303_peritoneal_inflammation | 3.68710625 |
| 5 | MP0002419_abnormal_innate_immunity | 3.15989311 |
| 6 | MP0009785_altered_susceptibility_to | 2.99820534 |
| 7 | MP0001800_abnormal_humoral_immune | 2.92662855 |
| 8 | MP0005671_abnormal_response_to | 2.90103520 |
| 9 | MP0005025_abnormal_response_to | 2.87187117 |
| 10 | MP0000685_abnormal_immune_system | 2.78729096 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.78113728 |
| 12 | MP0001790_abnormal_immune_system | 2.61046465 |
| 13 | MP0005387_immune_system_phenotype | 2.61046465 |
| 14 | MP0002723_abnormal_immune_serum | 2.59534035 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.50346630 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.48517977 |
| 17 | MP0008260_abnormal_autophagy | 2.47720720 |
| 18 | MP0001819_abnormal_immune_cell | 2.47625476 |
| 19 | MP0006082_CNS_inflammation | 2.47453649 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.40015816 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.31048846 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.20509186 |
| 23 | MP0002132_abnormal_respiratory_system | 2.20282137 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.17489836 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.02426713 |
| 26 | MP0002405_respiratory_system_inflammati | 1.97733377 |
| 27 | MP0003828_pulmonary_edema | 1.94322127 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.92381322 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.89512867 |
| 30 | MP0002398_abnormal_bone_marrow | 1.87803122 |
| 31 | MP0000716_abnormal_immune_system | 1.86479152 |
| 32 | MP0005451_abnormal_body_composition | 1.79763675 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.76801441 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.75342011 |
| 35 | MP0004883_abnormal_blood_vessel | 1.73884273 |
| 36 | MP0004381_abnormal_hair_follicle | 1.70527909 |
| 37 | MP0009278_abnormal_bone_marrow | 1.66308798 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.64752933 |
| 39 | MP0009764_decreased_sensitivity_to | 1.64254437 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.63730538 |
| 41 | MP0003866_abnormal_defecation | 1.62106174 |
| 42 | MP0002722_abnormal_immune_system | 1.56278440 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.55422495 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.54330295 |
| 45 | MP0004947_skin_inflammation | 1.53539134 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.48014938 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.46608508 |
| 48 | MP0002429_abnormal_blood_cell | 1.44797212 |
| 49 | MP0000858_altered_metastatic_potential | 1.43345775 |
| 50 | MP0008469_abnormal_protein_level | 1.41515417 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.39989831 |
| 52 | MP0005164_abnormal_response_to | 1.37159511 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.34572286 |
| 54 | MP0003075_altered_response_to | 1.33693110 |
| 55 | MP0005310_abnormal_salivary_gland | 1.29387242 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.28480729 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.28480729 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.26997419 |
| 59 | MP0003690_abnormal_glial_cell | 1.19979018 |
| 60 | MP0001851_eye_inflammation | 1.17720814 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.10104521 |
| 62 | MP0005166_decreased_susceptibility_to | 1.02645315 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 0.97152541 |
| 64 | MP0003448_altered_tumor_morphology | 0.94872774 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93572441 |
| 66 | MP0000015_abnormal_ear_pigmentation | 0.91366690 |
| 67 | MP0004510_myositis | 0.90265234 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 0.87602104 |
| 69 | MP0008004_abnormal_stomach_pH | 0.86738451 |
| 70 | MP0003045_fibrosis | 0.86185559 |
| 71 | MP0003787_abnormal_imprinting | 0.84557949 |
| 72 | MP0000343_altered_response_to | 0.83504286 |
| 73 | MP0009763_increased_sensitivity_to | 0.82770890 |
| 74 | MP0005390_skeleton_phenotype | 0.81473723 |
| 75 | MP0000604_amyloidosis | 0.80933928 |
| 76 | MP0002006_tumorigenesis | 0.79752551 |
| 77 | MP0004130_abnormal_muscle_cell | 0.77038739 |
| 78 | MP0001663_abnormal_digestive_system | 0.75704559 |
| 79 | MP0001853_heart_inflammation | 0.72992413 |
| 80 | MP0004484_altered_response_of | 0.71051765 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.69202021 |
| 82 | MP0008874_decreased_physiological_sensi | 0.68069085 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.67571050 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.65148656 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.64370984 |
| 86 | MP0000249_abnormal_blood_vessel | 0.63298575 |
| 87 | MP0002928_abnormal_bile_duct | 0.62346256 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.59851685 |
| 89 | MP0003795_abnormal_bone_structure | 0.59256163 |
| 90 | MP0005388_respiratory_system_phenotype | 0.57635690 |
| 91 | MP0002133_abnormal_respiratory_system | 0.57635690 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.57297803 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.57002059 |
| 94 | MP0003252_abnormal_bile_duct | 0.56811353 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.53976319 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.50691144 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.50644029 |
| 98 | MP0000490_abnormal_crypts_of | 0.49802998 |
| 99 | MP0001958_emphysema | 0.49189779 |
| 100 | MP0003091_abnormal_cell_migration | 0.48226287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.94837855 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.38468527 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.37345328 |
| 4 | Myositis (HP:0100614) | 6.29986198 |
| 5 | Orchitis (HP:0100796) | 6.22498766 |
| 6 | Optic neuritis (HP:0100653) | 5.99518512 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.99518512 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.27825002 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.25816979 |
| 10 | Stomatitis (HP:0010280) | 5.00389922 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 4.77452626 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65133863 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.46017754 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.34543472 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.26946995 |
| 16 | Recurrent skin infections (HP:0001581) | 4.16766571 |
| 17 | Keratoconjunctivitis (HP:0001096) | 4.14199620 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.13937911 |
| 19 | Obstructive lung disease (HP:0006536) | 4.13937911 |
| 20 | Meningitis (HP:0001287) | 4.09652990 |
| 21 | Encephalitis (HP:0002383) | 3.98006222 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.92985490 |
| 23 | Gingivitis (HP:0000230) | 3.91226160 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.77164116 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.70662045 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.70662045 |
| 27 | T lymphocytopenia (HP:0005403) | 3.64957362 |
| 28 | Hypochromic microcytic anemia (HP:0004840) | 3.62017011 |
| 29 | Peritonitis (HP:0002586) | 3.61746663 |
| 30 | Urticaria (HP:0001025) | 3.56684738 |
| 31 | Vasculitis (HP:0002633) | 3.55537447 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.51833838 |
| 33 | Chest pain (HP:0100749) | 3.35654370 |
| 34 | Arterial thrombosis (HP:0004420) | 3.33509966 |
| 35 | Hemoptysis (HP:0002105) | 3.28795845 |
| 36 | Gingival bleeding (HP:0000225) | 3.24358245 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.22932960 |
| 38 | Cellulitis (HP:0100658) | 3.21699227 |
| 39 | Increased IgE level (HP:0003212) | 3.19260332 |
| 40 | Hypochromic anemia (HP:0001931) | 3.11772770 |
| 41 | Episodic fever (HP:0001954) | 3.11029808 |
| 42 | Pulmonary infiltrates (HP:0002113) | 3.08395694 |
| 43 | Prolonged bleeding time (HP:0003010) | 3.06854117 |
| 44 | Anorexia (HP:0002039) | 3.04807543 |
| 45 | Pulmonary embolism (HP:0002204) | 2.93741226 |
| 46 | Leukocytosis (HP:0001974) | 2.93522644 |
| 47 | Abnormality of T cells (HP:0002843) | 2.81839483 |
| 48 | Gangrene (HP:0100758) | 2.69077781 |
| 49 | Epistaxis (HP:0000421) | 2.67769968 |
| 50 | Amyloidosis (HP:0011034) | 2.65012928 |
| 51 | Recurrent viral infections (HP:0004429) | 2.62733719 |
| 52 | Abnormality of the peritoneum (HP:0002585) | 2.60676940 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.57637261 |
| 54 | Osteomyelitis (HP:0002754) | 2.56470209 |
| 55 | Increased IgM level (HP:0003496) | 2.53122963 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.52342270 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.44915819 |
| 58 | Sepsis (HP:0100806) | 2.43612370 |
| 59 | Granulocytopenia (HP:0001913) | 2.41730998 |
| 60 | Microcytic anemia (HP:0001935) | 2.38348204 |
| 61 | Abnormality of the endocardium (HP:0004306) | 2.37408384 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 2.36004415 |
| 63 | Keratitis (HP:0000491) | 2.26379187 |
| 64 | Pustule (HP:0200039) | 2.25394471 |
| 65 | Acute hepatic failure (HP:0006554) | 2.23692398 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.22646442 |
| 67 | Glomerulopathy (HP:0100820) | 2.21448467 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.19631061 |
| 69 | Eosinophilia (HP:0001880) | 2.17825435 |
| 70 | Lymphopenia (HP:0001888) | 2.16031902 |
| 71 | Vertigo (HP:0002321) | 2.14091664 |
| 72 | Viral hepatitis (HP:0006562) | 2.13526969 |
| 73 | Slow saccadic eye movements (HP:0000514) | 2.09046328 |
| 74 | Acne (HP:0001061) | 2.07615102 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06970615 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.03581125 |
| 77 | Skin ulcer (HP:0200042) | 2.03377895 |
| 78 | Petechiae (HP:0000967) | 2.01816578 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.00588658 |
| 80 | Colitis (HP:0002583) | 1.96737237 |
| 81 | Recurrent pneumonia (HP:0006532) | 1.96709967 |
| 82 | Abnormality of the pericardium (HP:0001697) | 1.96563174 |
| 83 | Chronic otitis media (HP:0000389) | 1.93912558 |
| 84 | Cheilitis (HP:0100825) | 1.93411625 |
| 85 | Thrombophlebitis (HP:0004418) | 1.92271006 |
| 86 | Polyneuropathy (HP:0001271) | 1.89993781 |
| 87 | Difficulty running (HP:0009046) | 1.87607487 |
| 88 | Premature loss of primary teeth (HP:0006323) | 1.87182015 |
| 89 | IgM deficiency (HP:0002850) | 1.86857033 |
| 90 | Abnormal platelet volume (HP:0011876) | 1.86329415 |
| 91 | Abnormality of eosinophils (HP:0001879) | 1.85797083 |
| 92 | Metaphyseal cupping (HP:0003021) | 1.85573067 |
| 93 | Skin rash (HP:0000988) | 1.81987900 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.76481829 |
| 95 | Polycythemia (HP:0001901) | 1.76328769 |
| 96 | Amaurosis fugax (HP:0100576) | 1.75412261 |
| 97 | Toxemia of pregnancy (HP:0100603) | 1.70390293 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70127296 |
| 99 | Hepatosplenomegaly (HP:0001433) | 1.69629659 |
| 100 | Hypermelanotic macule (HP:0001034) | 1.67845957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.97192318 |
| 2 | IRAK4 | 3.61568986 |
| 3 | BLK | 3.41476625 |
| 4 | MAP2K3 | 3.23660867 |
| 5 | MAP4K1 | 3.09672937 |
| 6 | CSK | 2.93719515 |
| 7 | TYK2 | 2.80505530 |
| 8 | FES | 2.55036480 |
| 9 | ERN1 | 2.50777317 |
| 10 | GRK6 | 2.35133590 |
| 11 | EPHB1 | 2.25217565 |
| 12 | ZAP70 | 2.03474996 |
| 13 | TNK2 | 1.96977479 |
| 14 | FGR | 1.92849296 |
| 15 | TXK | 1.92526866 |
| 16 | BTK | 1.87112692 |
| 17 | JAK3 | 1.86134804 |
| 18 | HCK | 1.77205081 |
| 19 | MAP3K3 | 1.70444564 |
| 20 | SYK | 1.68191185 |
| 21 | TAOK1 | 1.65923512 |
| 22 | IKBKE | 1.61088620 |
| 23 | PRPF4B | 1.60306466 |
| 24 | JAK2 | 1.59818014 |
| 25 | KSR2 | 1.58235599 |
| 26 | MAP3K14 | 1.57325250 |
| 27 | YES1 | 1.52847385 |
| 28 | LYN | 1.44461071 |
| 29 | IRAK1 | 1.43819210 |
| 30 | MAP3K11 | 1.40292623 |
| 31 | MAP3K2 | 1.39820145 |
| 32 | JAK1 | 1.39226949 |
| 33 | MAP3K1 | 1.38164673 |
| 34 | TAOK3 | 1.34132251 |
| 35 | MAP3K6 | 1.27438187 |
| 36 | IRAK2 | 1.27247129 |
| 37 | TBK1 | 1.14022468 |
| 38 | BMPR2 | 1.13262869 |
| 39 | LCK | 1.11692276 |
| 40 | ITK | 1.11292196 |
| 41 | CSF1R | 1.06683198 |
| 42 | MAP3K13 | 1.05664444 |
| 43 | MATK | 1.04316502 |
| 44 | TEC | 1.03723969 |
| 45 | SIK3 | 1.03481591 |
| 46 | LRRK2 | 1.02544027 |
| 47 | MARK2 | 0.93075755 |
| 48 | KIT | 0.92888750 |
| 49 | MARK3 | 0.92884942 |
| 50 | FGFR3 | 0.91639197 |
| 51 | MAP2K4 | 0.91136020 |
| 52 | PIK3CG | 0.90699902 |
| 53 | PTK6 | 0.89821118 |
| 54 | PDK1 | 0.82541121 |
| 55 | STK10 | 0.79819688 |
| 56 | CDK19 | 0.79815528 |
| 57 | PTK2B | 0.78575152 |
| 58 | RAF1 | 0.77594332 |
| 59 | MAP3K5 | 0.76248229 |
| 60 | TGFBR2 | 0.75540018 |
| 61 | KSR1 | 0.71075875 |
| 62 | PDPK1 | 0.68813536 |
| 63 | FYN | 0.68334409 |
| 64 | IKBKB | 0.68078340 |
| 65 | PRKD2 | 0.68075890 |
| 66 | EPHA3 | 0.66842347 |
| 67 | STK11 | 0.66342520 |
| 68 | DYRK1B | 0.66336418 |
| 69 | SGK3 | 0.62336716 |
| 70 | MAP2K6 | 0.61916147 |
| 71 | NLK | 0.60961246 |
| 72 | TAOK2 | 0.60044648 |
| 73 | FGFR4 | 0.58370390 |
| 74 | SIK2 | 0.55344579 |
| 75 | TESK2 | 0.55074096 |
| 76 | MAP3K7 | 0.54453713 |
| 77 | RET | 0.53998020 |
| 78 | WNK1 | 0.53344644 |
| 79 | DYRK3 | 0.52651351 |
| 80 | SGK2 | 0.52278674 |
| 81 | PRKCQ | 0.50689803 |
| 82 | TRIB3 | 0.50237552 |
| 83 | STK38 | 0.48769649 |
| 84 | CAMKK2 | 0.46892994 |
| 85 | MAPK12 | 0.44771895 |
| 86 | PIM1 | 0.42788577 |
| 87 | HIPK2 | 0.42233127 |
| 88 | DAPK2 | 0.41930394 |
| 89 | SMG1 | 0.39219808 |
| 90 | MAPKAPK2 | 0.38986163 |
| 91 | MAPK7 | 0.37063140 |
| 92 | CDC42BPA | 0.34997364 |
| 93 | PRKCZ | 0.34181865 |
| 94 | RPS6KC1 | 0.33982492 |
| 95 | RPS6KL1 | 0.33982492 |
| 96 | CAMKK1 | 0.33728167 |
| 97 | GRK7 | 0.32522555 |
| 98 | RPS6KA6 | 0.29823098 |
| 99 | PRKG2 | 0.29309235 |
| 100 | ACVR1B | 0.26995070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.23923120 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.07475120 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85447227 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.46911338 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34661593 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.31373005 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24154092 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.21770778 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13103659 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11145232 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.01170544 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.99645043 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.93222078 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91946687 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.87861359 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.84205480 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81299576 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79424926 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.74166159 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67675401 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64466971 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64011335 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60077225 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53960452 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.53174313 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47965426 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46947611 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46548171 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45032522 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.44788154 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43646816 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42517442 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37865347 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31600764 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29559180 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28064055 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27964763 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.24797466 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24343490 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.15814582 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.14759867 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.05355352 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05269639 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04579636 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.03818347 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.99097539 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.98730726 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97752016 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96676326 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95344261 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94782502 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90965475 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89677630 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89314682 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86086662 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85650132 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83207153 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81461639 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79496884 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77047952 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.76986776 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76848179 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.76265377 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75452323 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74311859 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73151009 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72515458 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71783923 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67081315 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66970767 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66412657 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64528677 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63769818 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.63425138 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62965818 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62138041 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61804009 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60415438 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59729533 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59152552 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57924046 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57621640 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55781455 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53970567 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53934445 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.52771231 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50853884 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.49631567 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49502424 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48974962 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48008389 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44588600 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43455232 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.42858595 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.42452451 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40718231 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38910945 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38523258 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37413928 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36370322 |

